Browse by Phase
Phase 3 Clinical Trials
Phase 3 trials compare a new drug or treatment against the current standard of care in a large population (300–3,000+ participants). Successful Phase 3 results are the basis for regulatory approval.
Total Trials
514
Recruiting Now
514
Top Conditions in Phase 3
NCT04520074 Phase 3
Recruiting
Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer ...
Condition
Ovarian Cancer
Enrollment
590 pts
Location
China
Sponsor
Fudan University
NCT06497959 Phase 3
Recruiting
Study of Placental Vascularization Using Contrast Ultrasound
Condition
Fetal Growth Restriction
Enrollment
30 pts
Location
France
Sponsor
Central Hospital, Nancy, Franc
NCT06574503 Phase 3
Recruiting
Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure...
Condition
Influenza
Enrollment
748 pts
Location
China
Sponsor
Jiangxi Qingfeng Pharmaceutica
NCT04178174 Phase 3
Recruiting
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
Condition
Head and Neck Cancer
Enrollment
360 pts
Location
Canada
Sponsor
Centre hospitalier de l'Univer
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
NCT06044623 Phase 3
Recruiting
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kina...
Condition
Metastatic Breast Cancer
Enrollment
495 pts
Location
Finland, Greece, Italy
Sponsor
Region Örebro County
NCT06349941 Phase 3
Recruiting
Home-based Cardiac Rehabilitation in Heart Failure
Condition
Heart Failure
Enrollment
332 pts
Location
United States
Sponsor
University of Texas Southweste
NCT06262594 Phase 3
Recruiting
Lemborexant Treatment of Insomnia Linked to Epilepsy
Condition
Epilepsy
Enrollment
26 pts
Location
United States, Canada
Sponsor
University of Manitoba
NCT05784246 Phase 3
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to ...
Condition
Ulcerative Colitis
Enrollment
60 pts
Location
United States, Belgium, Canada
Sponsor
Eli Lilly and Company
NCT04495088 Phase 3
Recruiting
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients W...
Condition
Rectal Cancer
Enrollment
550 pts
Location
Germany
Sponsor
Ralf Hofheinz
NCT05653453 Phase 3
Recruiting
Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bo...
Condition
Locally Advanced Pancreatic Cancer
Enrollment
512 pts
Location
China
Sponsor
Jiangsu Healthy Life Innovatio
NCT05703672 Phase 3
Recruiting
Switching to E-cigarettes in Smokers Not Interested in Quitting
Condition
Smoking Reduction
Enrollment
500 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06674460 Phase 3
Recruiting
Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets ...
Condition
Cerebral Small Vessel Disease
Enrollment
600 pts
Location
China
Sponsor
Peking Union Medical College H
NCT07393542 Phase 3
Recruiting
A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urotheli...
Condition
Locally Advanced or Metastatic Urothelial Carcinoma
Enrollment
462 pts
Location
China
Sponsor
Suzhou Suncadia Biopharmaceuti
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
NCT06091254 Phase 3
Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Work...
Condition
Follicular Lymphoma (FL)
Enrollment
822 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
NCT05006482 Phase 3
Recruiting
Geriatric Evaluation and Management With Survivorship Health Education for Older...
Condition
Lymphoma
Enrollment
668 pts
Location
United States
Sponsor
University of Rochester
NCT07193459 Phase 3
Recruiting
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Condition
Type 2 Diabetes
Enrollment
360 pts
Location
China
Sponsor
Hangzhou Zhongmei Huadong Phar
NCT07107256 Phase 3
Recruiting
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal...
Condition
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Enrollment
246 pts
Location
China
Sponsor
Shanghai Chia Tai Tianqing Pha
NCT06974851 Phase 3
Recruiting
A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Sub...
Condition
Bstructive Sleep Apnea (OSA) and Obesity
Enrollment
140 pts
Location
China
Sponsor
Fujian Shengdi Pharmaceutical
NCT07040813 Phase 3
Recruiting
The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumto...
Condition
Migraine
Enrollment
450 pts
Location
Norway
Sponsor
Oslo University Hospital
NCT06716203 Phase 3
Recruiting
A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Di...
Condition
Type 2 Diabetes Mellitus (T2DM)
Enrollment
207 pts
Location
China
Sponsor
BrightGene Bio-Medical Technol
NCT05561127 Phase 3
Recruiting
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Condition
Bowel; Stricture
Enrollment
171 pts
Location
United States
Sponsor
GIE Medical
NCT03785288 Phase 3
Recruiting
Vaginal Cuff Brachytherapy Fractionation Study
Condition
Endometrial Cancer
Enrollment
258 pts
Location
United States
Sponsor
Kara Romano, MD
NCT05737303 Phase 3
Recruiting
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Can...
Condition
Epithelial Ovarian Carcinoma Stage III
Enrollment
538 pts
Location
China
Sponsor
Women's Hospital School Of Med